Future studies and clinical trials will test the validity of this Aβs•CaSR signalling-based hypothesis and the entailed therapeutic remedies for hitherto unforgiving Alzheimer’s disease. Here, CASR is linked to early-onset autosomal dominant Alzheimer disease.